Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ASLAN Pharmaceuticals logo — A clinical-stage immunology focused biopharmaceutical compan...

ASLAN Pharmaceuticals

A clinical-stage immunology focused biopharmaceutical company.

Founded 2010 Singapore Singapore 44 employees Post Ipo Equity Total: $186.00M Biotechnology, Health Care +1

General Information

Company Name ASLAN Pharmaceuticals
Founded Year 2010
Location Singapore Singapore
Employees 44
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Post Ipo Equity
Social

Get notified when ASLAN Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ASLAN Pharmaceuticals

ASLAN Pharmaceuticals is a clinical-stage immunology focused biopharmaceutical company headquartered in Singapore. The company, founded in 2010, is dedicated to developing innovative treatments to enhance the lives of patients. ASLAN is actively involved in the development of eblasakimab, a potential first-in-class antibody targeting the IL-13 receptor in moderate-to-severe atopic dermatitis, and farudodstat, a potent oral inhibitor of the enzyme DHODH, as a potential first-in-class treatment for alopecia areata. The company operates from San Mateo, California and Singapore. In its most recent funding round on 13 March 2024, ASLAN Pharmaceuticals secured a $5.00M Post-IPO Equity investment. The investors contributing to this funding round were not specified. For more information, visit www.aslanpharma.com. ASLAN Pharmaceuticals represents a promising player in the biotechnology, health care, and pharmaceutical industries and exhibits potential for significant growth and impact in the healthcare sector.

Taxonomy: biopharmaceutical, immunology, clinical-stage, eblasakimab, IL-13 receptor, atopic dermatitis, farudodstat, alopecia areata, drug development, clinical trials, innovation, biomedical research, pharmaceutical company, medical treatment

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 13 Mar 2024
Post-IPO Debt •••••• 2
Investor Investor
13 Jul 2021
Post-IPO Equity •••••• 2
Investor
•••• •••• 		25 Feb 2021
Post-IPO Equity •••••• - 05 Dec 2019
Post-IPO Debt •••••• - 18 Oct 2019

View All 10 Funding Rounds

ASLAN Pharmaceuticals Alternatives & Competitors

ASLAN Pharmaceuticals vs
Diamond Therapeutics
Diamond Therapeutics Canada

Revolutionizing the treatment of mental health

Series Unknown
9 employees
Biotechnology, Health Care
Compare ASLAN Pharmaceuticals vs Diamond Therapeutics
ASLAN Pharmaceuticals vs
Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. United States

Framing the future of autoimmune diseases

Post Ipo Equity
163 employees
Biotechnology, Health Care
Compare ASLAN Pharmaceuticals vs Viridian Therapeutics, Inc.
ASLAN Pharmaceuticals vs
Apitope
Apitope Belgium

Develops drugs for treatments of allergic diseases

Series B
1 employees
Biotechnology, Health Care
Compare ASLAN Pharmaceuticals vs Apitope

FAQ About ASLAN Pharmaceuticals

A clinical-stage immunology focused biopharmaceutical company.
ASLAN Pharmaceuticals was founded in 2010.
ASLAN Pharmaceuticals is headquartered in Singapore.
ASLAN Pharmaceuticals operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
ASLAN Pharmaceuticals has approximately 44 employees.
ASLAN Pharmaceuticals has completed 10 funding rounds, raising a total of $186.00M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to ASLAN Pharmaceuticals include Diamond Therapeutics, Viridian Therapeutics, Inc., Apitope, Syndax Pharmaceuticals, Simcha Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ASLAN Pharmaceuticals and Diamond Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ASLAN Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy